check
Latest Progresses in Allergic Diseases Biomarkers: Asthma and Atopic Dermatitis. | School of Pharmacy

Latest Progresses in Allergic Diseases Biomarkers: Asthma and Atopic Dermatitis.

Citation:

Pier Giorgio Puzzovio and Levi-Schaffer, Francesca . 2021. “Latest Progresses In Allergic Diseases Biomarkers: Asthma And Atopic Dermatitis.”. Frontiers In Pharmacology, 12, Pp. 747364. doi:10.3389/fphar.2021.747364.

Abstract:

In the last years, the understanding of the pathologic mechanisms of asthma and atopic dermatitis, both characterized by allergic inflammation, has greatly improved. However, it is evident that both diseases present with high heterogeneity, which complicates the diagnosis and the therapeutic approach of the patients. Moreover, some of the currently available strategies to treat asthma and atopic dermatitis are still mostly controlling the symptoms, but not to lead towards full healing, thus having these two diseases labelled as unmet clinical needs by WHO. Therefore, the "one-size-fits-all" strategy is outdated for asthma and atopic dermatitis, and there is the need of better methods to clearly diagnose the disease and tailor the therapy according to the specific symptomatology. In this regard, the use of biomarkers has been advanced in order to characterize both diseases according to their clinical signs and to facilitate the subsequent treatment. Despite the advancements made in this regard, there is still need for better and more sensitive biomarkers and for less invasive sampling methodologies, with the aim to diagnose specifically each manifestation of asthma and atopic dermatitis and to provide the best treatment with the least suffering for the patients.